Pembrolizumab-induced mucositis in a patient with recurrent hypopharynx squamous cell cancer. Pelster MS, Mott F, Lewin J. Laryngoscope 2020;130:E140-E143.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Pelster MS, Mott F, Lewin J. Pembrolizumab-induced mucositis in a patient with recurrent hypopharynx squamous cell cancer. Laryngoscope 2020;130:E140-E143.
PMID: 31074845